Corneal cross-linking treatment of keratoconus

Keratoconus as the most common cause of ectasia is one of the leading cause of corneal transplants worldwide. The current available therapies do not modify the underlying pathogenesis of the disease, and none of the available approaches but corneal transplant hinder the ongoing ectasia. Several stud...

Full description

Bibliographic Details
Main Authors: Mahgol Farjadnia, Mohammad Naderan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Oman Journal of Ophthalmology
Subjects:
Online Access:http://www.ojoonline.org/article.asp?issn=0974-620X;year=2015;volume=8;issue=2;spage=86;epage=91;aulast=Farjadnia
id doaj-47b6c1bc10ba45c5bdf7b0a7b5be99d1
record_format Article
spelling doaj-47b6c1bc10ba45c5bdf7b0a7b5be99d12020-11-24T23:09:15ZengWolters Kluwer Medknow PublicationsOman Journal of Ophthalmology0974-620X2015-01-0182869110.4103/0974-620X.159105Corneal cross-linking treatment of keratoconusMahgol FarjadniaMohammad NaderanKeratoconus as the most common cause of ectasia is one of the leading cause of corneal transplants worldwide. The current available therapies do not modify the underlying pathogenesis of the disease, and none of the available approaches but corneal transplant hinder the ongoing ectasia. Several studies document Crosslink defect between collagen fibrils in the pathogenesis of keratoconus. Collagen cross link is a relatively new approach that with the application of the riboflavin and ultraviolet A, new covalent bands reform. Subjective and objective results following this method seem to be promising. Endothelial damage besides other deep structural injury, which is the major concern of this technique have not yet been reported, when applying the standard method.http://www.ojoonline.org/article.asp?issn=0974-620X;year=2015;volume=8;issue=2;spage=86;epage=91;aulast=FarjadniaCorneal cross linkingkeratoconusultraviolet A
collection DOAJ
language English
format Article
sources DOAJ
author Mahgol Farjadnia
Mohammad Naderan
spellingShingle Mahgol Farjadnia
Mohammad Naderan
Corneal cross-linking treatment of keratoconus
Oman Journal of Ophthalmology
Corneal cross linking
keratoconus
ultraviolet A
author_facet Mahgol Farjadnia
Mohammad Naderan
author_sort Mahgol Farjadnia
title Corneal cross-linking treatment of keratoconus
title_short Corneal cross-linking treatment of keratoconus
title_full Corneal cross-linking treatment of keratoconus
title_fullStr Corneal cross-linking treatment of keratoconus
title_full_unstemmed Corneal cross-linking treatment of keratoconus
title_sort corneal cross-linking treatment of keratoconus
publisher Wolters Kluwer Medknow Publications
series Oman Journal of Ophthalmology
issn 0974-620X
publishDate 2015-01-01
description Keratoconus as the most common cause of ectasia is one of the leading cause of corneal transplants worldwide. The current available therapies do not modify the underlying pathogenesis of the disease, and none of the available approaches but corneal transplant hinder the ongoing ectasia. Several studies document Crosslink defect between collagen fibrils in the pathogenesis of keratoconus. Collagen cross link is a relatively new approach that with the application of the riboflavin and ultraviolet A, new covalent bands reform. Subjective and objective results following this method seem to be promising. Endothelial damage besides other deep structural injury, which is the major concern of this technique have not yet been reported, when applying the standard method.
topic Corneal cross linking
keratoconus
ultraviolet A
url http://www.ojoonline.org/article.asp?issn=0974-620X;year=2015;volume=8;issue=2;spage=86;epage=91;aulast=Farjadnia
work_keys_str_mv AT mahgolfarjadnia cornealcrosslinkingtreatmentofkeratoconus
AT mohammadnaderan cornealcrosslinkingtreatmentofkeratoconus
_version_ 1725610742376300544